Total Payments
$84,569
2024 Payments
$7,436
Companies
10
Transactions
103
Payment Breakdown by Category
Consulting$53,075 (62.8%)
Research$11,037 (13.1%)
Other$10,358 (12.2%)
Travel$5,196 (6.1%)
Food & Beverage$4,903 (5.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $53,075 | 16 | 62.8% |
| Unspecified | $11,037 | 16 | 13.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,358 | 3 | 12.2% |
| Travel and Lodging | $5,196 | 26 | 6.1% |
| Food and Beverage | $4,903 | 42 | 5.8% |
Payments by Type
General
$73,532
87 transactions
Research
$11,037
16 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $45,754 | 46 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $18,185 | 12 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $12,481 | 16 | $0 (2024) |
| Medexus Pharma, Inc. | $2,040 | 1 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $1,919 | 18 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,650 | 1 | $0 (2021) |
| National Marrow Donor Program | $1,201 | 3 | $0 (2024) |
| Millennium Pharmaceuticals, Inc. | $610.00 | 2 | $0 (2017) |
| Adaptive Biotechnologies Corporation | $606.40 | 3 | $0 (2021) |
| Horizon Pharma plc | $122.97 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,436 | 9 | SANOFI-AVENTIS U.S. LLC ($3,656) |
| 2023 | $6,004 | 8 | SANOFI-AVENTIS U.S. LLC ($5,154) |
| 2022 | $9,424 | 6 | SANOFI-AVENTIS U.S. LLC ($9,375) |
| 2021 | $13,037 | 9 | Novartis Pharmaceuticals Corporation ($7,468) |
| 2020 | $15,317 | 5 | Novartis Pharmaceuticals Corporation ($10,717) |
| 2019 | $12,271 | 18 | Novartis Pharmaceuticals Corporation ($12,150) |
| 2018 | $9,959 | 20 | Novartis Pharmaceuticals Corporation ($5,113) |
| 2017 | $11,122 | 28 | Novartis Pharmaceuticals Corporation ($9,438) |
All Payment Transactions
103 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | SANOFI-AVENTIS U.S. LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,656.00 | General |
| 12/09/2024 | Novartis Pharmaceuticals Corporation | KYMRIAH (Drug) | Food and Beverage | In-kind items and services | $133.59 | General |
| Category: Oncology | ||||||
| 12/07/2024 | JAZZ PHARMACEUTICALS INC. | RYLAZE (Drug), VYXEOS, Defitelio | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/17/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $771.93 | General |
| 08/07/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $214.56 | General |
| 06/13/2024 | Medexus Pharma, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,040.00 | General |
| 04/28/2024 | National Marrow Donor Program | — | Food and Beverage | In-kind items and services | $214.51 | General |
| 04/03/2024 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $141.68 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 02/22/2024 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $140.51 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/14/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | KYMRIAH (Drug) | Consulting Fee | Cash or cash equivalent | $735.00 | General |
| Category: Oncology | ||||||
| 10/27/2023 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Consulting Fee | Cash or cash equivalent | $4,310.00 | General |
| Category: Oncology | ||||||
| 10/27/2023 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | In-kind items and services | $258.75 | General |
| Category: Oncology | ||||||
| 10/27/2023 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $248.84 | General |
| Category: Oncology | ||||||
| 10/27/2023 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | In-kind items and services | $248.13 | General |
| Category: Oncology | ||||||
| 10/27/2023 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | Cash or cash equivalent | $58.00 | General |
| Category: Oncology | ||||||
| 10/27/2023 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | Cash or cash equivalent | $30.26 | General |
| Category: Oncology | ||||||
| 06/27/2023 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug) | Food and Beverage | In-kind items and services | $114.58 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/04/2022 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Consulting Fee | Cash or cash equivalent | $7,835.29 | General |
| Category: Oncology | ||||||
| 11/04/2022 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | In-kind items and services | $679.90 | General |
| Category: Oncology | ||||||
| 11/04/2022 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Food and Beverage | In-kind items and services | $303.64 | General |
| Category: Oncology | ||||||
| 11/04/2022 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | In-kind items and services | $291.89 | General |
| Category: Oncology | ||||||
| 11/04/2022 | SANOFI-AVENTIS U.S. LLC | REZUROCK (Drug) | Travel and Lodging | In-kind items and services | $264.24 | General |
| Category: Oncology | ||||||
| 05/04/2022 | JAZZ PHARMACEUTICALS INC. | DEFITELIO (Drug), VYXEOS | Food and Beverage | In-kind items and services | $49.48 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/10/2021 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Consulting Fee | Cash or cash equivalent | $4,392.00 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2021 | Novartis Pharmaceuticals Corporation | KYMRIAH (Biological) | Food and Beverage | Cash or cash equivalent | $74.99 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | Novartis Pharmaceuticals Corporation | $8,125 | 2 |
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $1,860 | 7 |
| PCYC-1140-IM | Pharmacyclics LLC, An AbbVie Company | $1,053 | 7 |
About Dr. Michael Verneris, MD
Dr. Michael Verneris, MD is a Pediatrics healthcare provider based in Aurora, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336240332.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Verneris, MD has received a total of $84,569 in payments from pharmaceutical and medical device companies, with $7,436 received in 2024. These payments were reported across 103 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($53,075).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Hematology-Oncology, Pediatric Hematology-Oncology
- Location Aurora, CO
- Active Since 09/25/2006
- Last Updated 12/05/2018
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1336240332
Products in Payments
- KYMRIAH (Biological) $33,510
- REZUROCK (Drug) $14,529
- DEFITELIO (Drug) $8,468
- Defitelio (Drug) $3,827
- GAMMAGARD LIQUID (Biological) $1,650
- Ibrutinib (Drug) $1,053
- KYMRIAH (Drug) $868.59
- Imbruvica (Drug) $866.17
- clonoSEQ (Device) $606.40
- RYLAZE (Drug) $123.12
- ACTIMMUNE (Drug) $122.97
- Erwinaze (Drug) $63.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Aurora
Natalie Nokoff, Md, MD
Pediatrics — Payments: $152,727
Pediatrics $152,727
Dr. Matthew Greenhawt, Md, Mba, MD, MBA
Pediatrics — Payments: $120,823
Pediatrics $120,823
Stephen Daniels, Md, Phd, MD, PHD
Pediatrics — Payments: $85,612
Pediatrics $85,612
Amanda Dempsey, Md Phd, MD PHD
Pediatrics — Payments: $78,729
Pediatrics $78,729
Dustin Nash, Md, MD
Pediatrics — Payments: $29,628
Pediatrics $29,628
Dr. Taizo Nakano, M.d, M.D
Pediatrics — Payments: $21,976
Pediatrics $21,976